Some consumers take tiny doses of Ozempic and other GLP-1 drugs or stretch out doses to cut costs and side effects.

Weight-loss drugs may lower cancer risk in people with diabetes, a study suggests Illustration of a semaglutide peptide (blue) bound to its target glucagon-like peptide-1 (GLP-1, light pink).

men living north of 40 degrees latitude are at a higher risk of dying from prostate cancer than those living farther south. This may be explained by a reduction in the levels of sunlight ...

FROM sulphur burps to diarrhoea and nausea, there are many widely known Ozempic side effects – but there’s also a whole host of nasty long-term issues experts are only just uncovering.

Mounjaro, Ozempic and other fat-melting injections have ushered in a new era in the war on obesity, but have also been linked to other benefits, such as slashing heart attack risk.

GLP-1 drugs like Ozempic may lower the risk of obesity-related cancers, particularly colorectal cancer, among type 2 diabetes ...

Weight loss injections work by making you feel fuller and less hungry. There are plenty of weight loss medication options to ...

Objectives To investigate associations between daily physical activity, activity intensity and step counts with incident cancer risk. Methods Prospective analysis of UK Biobank participants who wore ...

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...

Experts already know that losing weight reduces the risk of cancer, but now they think weight-loss jabs may have a role ...

First-generation GLP-1 drugs like liraglutide (Saxenda) and exenatide (Byetta) were associated with a 41% lower risk of ...